These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1681 related articles for article (PubMed ID: 19331797)
1. Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation. Simpson EL; Duenas A; Holmes MW; Papaioannou D; Chilcott J Health Technol Assess; 2009 Mar; 13(17):iii, ix-x, 1-154. PubMed ID: 19331797 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of spinal cord stimulation therapy in management of chronic pain. Kumar K; Rizvi S Pain Med; 2013 Nov; 14(11):1631-49. PubMed ID: 23710759 [TBL] [Abstract][Full Text] [Related]
3. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure. McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762 [TBL] [Abstract][Full Text] [Related]
4. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018 [TBL] [Abstract][Full Text] [Related]
5. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model. Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842 [TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of a novel 10 kHz high-frequency spinal cord stimulation system in patients with failed back surgery syndrome (FBSS). Annemans L; Van Buyten JP; Smith T; Al-Kaisy A J Long Term Eff Med Implants; 2014; 24(2-3):173-83. PubMed ID: 25272216 [TBL] [Abstract][Full Text] [Related]
7. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy. Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652 [TBL] [Abstract][Full Text] [Related]
8. Spinal cord stimulation for failed back surgery syndrome: a decision-analytic model and cost-effectiveness analysis. Taylor RJ; Taylor RS Int J Technol Assess Health Care; 2005; 21(3):351-8. PubMed ID: 16110715 [TBL] [Abstract][Full Text] [Related]
9. A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context. Buxton M; Caine N; Chase D; Connelly D; Grace A; Jackson C; Parkes J; Sharples L Health Technol Assess; 2006 Aug; 10(27):iii-iv, ix-xi, 1-164. PubMed ID: 16904046 [TBL] [Abstract][Full Text] [Related]
10. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation. Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208 [TBL] [Abstract][Full Text] [Related]
11. Counting the costs: case management implications of spinal cord stimulation treatment for failed back surgery syndrome. Mekhail N; Wentzel DL; Freeman R; Quadri H Prof Case Manag; 2011; 16(1):27-36. PubMed ID: 21164332 [TBL] [Abstract][Full Text] [Related]
12. The cost-effectiveness of spinal cord stimulation for complex regional pain syndrome. Kemler MA; Raphael JH; Bentley A; Taylor RS Value Health; 2010; 13(6):735-42. PubMed ID: 20561326 [TBL] [Abstract][Full Text] [Related]
13. The effect of different treatment durations of clopidogrel in patients with non-ST-segment elevation acute coronary syndromes: a systematic review and value of information analysis. Rogowski W; Burch J; Palmer S; Craigs C; Golder S; Woolacott N Health Technol Assess; 2009 Jun; 13(31):iii-iv, ix-xi, 1-77. PubMed ID: 19573471 [TBL] [Abstract][Full Text] [Related]
14. Long-term Cost Utility of Spinal Cord Stimulation in Patients with Failed Back Surgery Syndrome. Farber SH; Han JL; Elsamadicy AA; Hussaini Q; Yang S; Pagadala P; Parente B; Xie J; Lad SP Pain Physician; 2017 Sep; 20(6):E797-E805. PubMed ID: 28934786 [TBL] [Abstract][Full Text] [Related]
18. 24-month Real-World Study of Spinal Cord Stimulation in Failed Back Surgery Patients with Refractory Pain. Perez C; Rojo E; Margarit C; Sanchez N; Blanco T; Munoz M; Crespo C; Ochoa D Pain Physician; 2021 Sep; 24(6):479-488. PubMed ID: 34554696 [TBL] [Abstract][Full Text] [Related]
19. Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation. Shepherd J; Jones J; Frampton GK; Tanajewski L; Turner D; Price A Health Technol Assess; 2008 Jun; 12(28):iii-iv, ix-95. PubMed ID: 18547499 [TBL] [Abstract][Full Text] [Related]
20. The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluation. Loveman E; Jones J; Hartwell D; Bird A; Harris P; Welch K; Clegg A Health Technol Assess; 2010 Mar; 14(19):1-204. PubMed ID: 20356561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]